Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05042661
Other study ID # TFang
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2021
Est. completion date December 31, 2023

Study information

Verified date October 2022
Source National Taipei University of Nursing and Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To discuss the effects of improving the irritable bowel syndrome patients' quality of life and defecation after implementing acupuncture-like Transcutaneous Electrical nerve stimulation.


Description:

This experiment will use a clinical design that will collect cases in a local teaching hospital. The way of convenience sampling will gather from the irritable bowel syndrome patients. After a questionnaire, randomly to make invention and control groups. Invention and control groups are 4 weeks and 3 weeks respectively. Each time will be for 20 minutes acupuncture-like transcutaneous electrical nerve stimulation treatment. The Control group will still have normal nursing. There will be 72 patients in two groups. The measured timing will be in the second, fourth, and eighth weeks after the prediction and invention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 72
Est. completion date December 31, 2023
Est. primary completion date February 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Those who are at least 20 years old (inclusive) and are willing to sign a written informed consent after explaining the purpose of the research. 2. A patient with irritable bowel syndrome diagnosed by a doctor for at least 6 months (inclusive). 3. Communicate in Mandarin or Hokkien. Exclusion Criteria: 1. Those who cannot take care of themselves in daily life. 2. Those who have had severe abdominal and colorectal surgery. 3. Those who have been diagnosed with inflammatory bowel disease or colorectal cancer. 4. Those with a history of mental illness, such as schizophrenia and obsessive- compulsive disorder. 5. Women who are pregnant, breastfeeding, and less than 12 months after delivery. 6. Other serious diseases, such as acute myocardial infarction, endocrine disease, decompensated cirrhosis, stroke, and end-stage renal disease, etc.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
acupuncture-like transcutaneous electrical nerve stimulation
The intervention group performed Al-TENS therapy 3 times a week for at least 20 minutes each time for 4 consecutive weeks. The second, fourth, and eighth week after the intervention.

Locations

Country Name City State
Taiwan Tsu Ying Fang New Taipei City

Sponsors (1)

Lead Sponsor Collaborator
National Taipei University of Nursing and Health Sciences

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Other Part 1: Basic personal information:Basic and disease information list 1 gender pretest
Other Part 1: Basic personal information:Basic and disease information list 2 Date of birth pretest
Other Part 1: Basic personal information:Basic and disease information list 3 marital status pretest
Other Part 1: Basic personal information:Basic and disease information list 4 education level pretest
Other Part 1: Basic personal information:Basic and disease information list 5 Work pretest
Other Part 1: Basic personal information:Basic and disease information list 6 religion pretest
Other Part 1: Basic personal information:Basic and disease information list 7 family history pretest
Other Part 1: Basic personal information:Basic and disease information list 8 History of chronic disease pretest
Other Basic and disease information list 9 smokes pretest
Other Part 1: Basic personal information:Basic and disease information list 10 drink wine pretest
Other Part 1: Basic personal information:Basic and disease information list 11 Betel nut pretest
Other Part 1: Basic personal information:Basic and disease information list 12 Sleep status pretest
Other Part 1: Basic personal information:Basic and disease information list 13 Special eating habits pretest
Other Part 1: Basic personal information:Basic and disease information list 14 Exercise habits pretest
Other Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 1 Irritable bowel disease onset time pretest
Other Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 2 Bowel movement pretest
Other Part 2: Symptoms of Irritable Bowel Syndrome:Basic and disease information list 3 treatment pretest
Primary WHOQOL-BREF,Taiwan version There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life. pretest
Primary WHOQOL-BREF,Taiwan version There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life 2 weeks after the pretest
Primary WHOQOL-BREF,Taiwan version There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life 4 weeks after the pretest
Primary WHOQOL-BREF,Taiwan version There are a total of 28 questions on this scale, of which 26 are common questions around the world, and the other 2 are local questions. This questionnaire is a positive question and a five-point scoring system. The higher the score, the better the quality of life 8 weeks after the pretest
Primary irritable bowel syndrome Severity Score There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms pretest
Primary irritable bowel syndrome Severity Score There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms 2 weeks after the pretest
Primary irritable bowel syndrome Severity Score There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms 4 weeks after the pretest
Primary irritable bowel syndrome Severity Score There are a total of 5 questions on this scale. This questionnaire is a positive question type. The score of each item can be from 0 to 100. Therefore, the overall severity of IBS ranges from 0 to 500. The severity of symptoms can be divided into mild; moderate; severe, the higher the score, the more severe the IBS symptoms 8 weeks after the pretest
Primary Irritable Bowel Syndrome Quality of Life This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34~170 points, the higher the score, the worse the quality of life pretest
Primary Irritable Bowel Syndrome Quality of Life This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34~170 points, the higher the score, the worse the quality of life 2 weeks after the pretest
Primary Irritable Bowel Syndrome Quality of Life This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34~170 points, the higher the score, the worse the quality of life 4 weeks after the pretest
Primary Irritable Bowel Syndrome Quality of Life This questionnaire has a total of 34 questions, all of which are positive questions, and are scored with five points, divided into 1 point = completely no, 2 points = a little bit, 3 points = medium, 4 points = equivalent, 5 points = extreme. The score range is 34~170 points, the higher the score, the worse the quality of life 8 weeks after the pretest
Primary Bristol Stool Form Scale The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, & Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms pretest
Primary Bristol Stool Form Scale The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, & Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms 2 weeks after the pretest
Primary Bristol Stool Form Scale The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, & Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms 4 weeks after the pretest
Primary Bristol Stool Form Scale The first and second types of stool show that the patient has constipation, the first type is more serious than the second type; the normal stool types are the third and fourth types, and the fifth to seventh types are suspected Diarrhea (Lewis, & Heaton, 1997), the above description indicates that the lower the score, the more severe the constipation symptoms, and vice versa, the more severe the diarrhea symptoms 8 weeks after the pretest
See also
  Status Clinical Trial Phase
Completed NCT03720314 - Microbiota Profiling in IBS
Recruiting NCT06166563 - Exercise, Irritable Bowel Syndrome and Fibromyalgia N/A
Completed NCT05213910 - Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains N/A
Recruiting NCT05985018 - Traditional Dietary Advice Vs. Mediterranean Diet in IBS N/A
Completed NCT04486469 - Efficacy of Physiotherapy Techniques on Irritable Bowel Syndrome (IBS). Pilot Study. N/A
Completed NCT06407609 - Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS N/A
Completed NCT04656730 - Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas Phase 4
Completed NCT04145856 - Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico Phase 4
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Active, not recruiting NCT03586622 - One Year Home Monitoring and Treatment of IBS Patients N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT06369753 - Visible Abdominal Distension N/A
Not yet recruiting NCT05157867 - In Vivo Effects of Amylase Trypsin Inhibitors N/A
Not yet recruiting NCT05100719 - The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) N/A
Recruiting NCT05001997 - Effects of Lactose-free Dairy Products on Athletes With Irritable Bowel Syndrome N/A
Recruiting NCT02953171 - Probiotics in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT02977975 - Lacto-fermented Sauerkraut in the Treatment of Irritable Bowel Syndrome N/A
Completed NCT03266068 - Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Completed NCT02980406 - The Role of FODMAPs in Upper GI Effects, Colonic Motor Activity and Gut-brain Signaling at the Behavioral Level N/A
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3